Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy

Archives of Disease in Childhood

Volumn 90, Issue 1, 2005, Pages 57-59

  Tan, M ^b   Appleton, R ^a  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DOPAMINE; ETHOSUXIMIDE; METHYLPHENIDATE; NORADRENALIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE;

ABSENCE; ATTENTION DEFICIT DISORDER; BENIGN CHILDHOOD EPILEPSY; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; HUMAN; PRIORITY JOURNAL; REVIEW; ROLANDIC EPILEPSY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; EPILEPSY; HUMANS; METHYLPHENIDATE; RISK FACTORS; TREATMENT OUTCOME;

EID: 11144225249     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.048504     Document Type: Review

References (27)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: APA Press, 1994.
2. Dunn DW, Austin JK, Harezlak J, et al. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003;45:50-4.
3. Sanchez-Carpentiro R, Neville B. Attentional ability in children with epilepsy. Epilepsia 2003;44:1340-9.
4. Gucuyener K, Erdemoglu K, Senol S, et al. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol 2003;18:109-12.
5. Gross-Tsur V, Manor O, van der Meere J, et al. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective. J Pediatr 1997;130:670-4.
6. National Institute for Clinical Excellence (NICE). Guidance on the use of methylphenidate (Ritalin, Equasym) for ADHD in childhood, NICE guidance no.13. London: National Institute for Clinical Excellence, 2000.
7. Scottish intercollegiate Guidelines Network (SIGN). Attention deficit and hyperkinetic disorders in children and young people, SIGN publication no.52. Edinburgh: SIGN, 2001.
8. Stein MA, Blondis TA, Schnitzler ER, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics 1996;98:748-56.
9. Weinberg WA, Harper CR, Schraufnagel CD, et al. Attention deficit hyperactivity disorder: a disease or a symptom complex. J Pediatr 1997;130:665-9.
10. Austin JK, Harezlak J, Dunn DW, et al. Behaviour problems in children before first recognised seizure. Pediatrics 2001;107:115-22.
11. Oostrom KJ, Schouten A, Kruitwagen CL, et al. Attention deficits are not characteristic of schoolchildren with newly diagnosed idiopathic or cryptogenic epilepsy. Epilepsia 2002;43:301-10.
12. Aldenkamp AP, Alpherts WCJ, Blennow G, et al. Withdrawal of antiepileptic medication in children - effects on cognitive function: the Multicenter Holmfrid Study. Neurology 1993;43:41-50.
13. Bourgeois BFD. Antiepileptic drugs, learning and behavior in childhood epilepsy. Epilepsia 1998;39:913-21.
14. Williams J, Bates, S, Griebel ML, et al. Does short-term antiepileptic drug treatment in children result in cognitive or behavioral changes. Epilepsia 1998;39:1064-9.
15. Semrud-Clikeman M, Wical B. Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40:211-15.
16. Piccirilli M, D'Alessandro P, Sciarma T, et al. Attentional problems in epilepsy: possible significance of epileptogenic focus. Epilepsia 1994;35:1091-6.
17. Williams J, Griebel ML, Dykman RA. Neuropsychological patterns in pediatric epilepsy. Seizure 1998;7:223-8.
18. Richer LP, Shevell MI, Rosenblatt BR. Epileptiform abnormalities in children with attention-deficit-hyperactivity disorder. Pediatr Neurol 2002;26:125-9.
19. Hughes JR, Deleo AJ, Melyn MA. The electroencephalogram in attention deficit-hyperactivity disorder: emphasis on epileptiform discharges. Epilepsy Behav 2000;1:271-7.
20. Holtmann M, Becker K, Kentner-Figura B, et al. Increased frequency of rolandic spikes in ADHD children. Epilepsia 2003;44:1241-4.
21. Becker K, Sinzig JK, Holtmann M. Attention deficits and subclinical epileptiform discharges: are EEG diagnostics in ADHD optional or essential? Dev Med Child Neurol 2004;46:431-2.
22. Anderson KV, Trojaborg W. Risk of development of epileptic seizures in children with subclinical "epileptogenic" EEG abnormalities. Egeskr Laeger 1993;155:1285-8.
23. Feldman H, Crumrine P, Handen BL, et al. Methylphenidate in children with seizures and attention deficit disorder. Am J Dis Child 1989;143:1081-6.
24. Clarke AR, Barry RJ, Bond D, et al. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology 2002;164:277-84.
25. Hemmer SA, Pasternak JF, Zecker SG, et al. Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24:99-102.
26. Wroblewski BA, Leary JM, Phelan AM, et al. Methylphenidate and seizure frequency in brain-injured patients with seizure disorders. J Clin Psychiatry 1992;53:86-9.
27. McBride MC, Wang DD, Torres CF. Methylphenidate in therapeutic doses does not lower seizure threshold [abstract]. Ann Neurol 1986;20:428.